RankAlpha logo
Back to Rankings

MAZE

Maze TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MAZE vs peer average
15/100
MAZE vs. peer average (F vs. B)
Grade spread
A 2 · B 3 · C 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

XERS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.55B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerXERSXeris Biopharma
MAZE
Maze Therapeutics
XERS
Xeris Biopharma
Grade
F
A
Momentum
15
61
Value
41
61
Sentiment
-
99
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs XERS

MAZE / XERS
Grade Position
Below peers
MAZE vs. peer average (F vs. B)
15/100
Momentum
15
XERS
Value
41
XERS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MAZE
1
XERS
Xeris Biopharma Holdings Inc Common
A
100/100
-4
2
TRAX
First Tracks Biotherapeutics Inc Common
N/A
-
-
3
TYRA
Tyra Biosciences Inc Common
B
80/100
-3
4
ABSI
Absci Corp Common
F
20/100
Even
5
VIR
Vir Biotechnology Inc Common
C
60/100
-2
XERS is the first peer returned for this comparison set.